Adjuvant Systemic Therapy in Breast Cancer

This workshop will provide in-depth insights into adjuvant systemic therapy, with a focus on advancements in endocrine treatments and the role of CDK4/6 inhibitors like ribociclib and abemaciclib. Participants will explore clinical evidence, invasive disease-free survival benefits, safety considerations, and patient-centric approaches. Interactive segments will include case studies and expert-led discussions to enhance practical understanding. Emphasis will also be on integrating emerging...